The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study.
Heiberg, M S
The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study. [electronic resource] - Annals of the rheumatic diseases Aug 2007 - 1038-42 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
0003-4967
10.1136/ard.2006.064808 doi
Adalimumab
Adult
Aged
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antirheumatic Agents--therapeutic use
Arthritis, Psoriatic--drug therapy
Chi-Square Distribution
Drug Therapy, Combination
Etanercept
Female
Follow-Up Studies
Humans
Immunoglobulin G--therapeutic use
Immunosuppressive Agents--therapeutic use
Infliximab
Joints--pathology
Logistic Models
Male
Methotrexate--therapeutic use
Middle Aged
Norway
Pain
Receptors, Tumor Necrosis Factor--therapeutic use
Treatment Outcome
Tumor Necrosis Factor-alpha--antagonists & inhibitors
The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study. [electronic resource] - Annals of the rheumatic diseases Aug 2007 - 1038-42 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
0003-4967
10.1136/ard.2006.064808 doi
Adalimumab
Adult
Aged
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antirheumatic Agents--therapeutic use
Arthritis, Psoriatic--drug therapy
Chi-Square Distribution
Drug Therapy, Combination
Etanercept
Female
Follow-Up Studies
Humans
Immunoglobulin G--therapeutic use
Immunosuppressive Agents--therapeutic use
Infliximab
Joints--pathology
Logistic Models
Male
Methotrexate--therapeutic use
Middle Aged
Norway
Pain
Receptors, Tumor Necrosis Factor--therapeutic use
Treatment Outcome
Tumor Necrosis Factor-alpha--antagonists & inhibitors